AGP Picks
View all

Middle East News Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.

Press releases published on July 30, 2026

Skyharbour Signs Definitive Agreement with Purecore to Option its Yurchison Uranium Property in the Athabasca Basin
Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
GoldHaven Reports High-Grade Gold Assays Up to 55.3 g/t Au at Magno
Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June
NevGold Appoints Scott Bensing as Independent Non-Executive Director; Key US-Based External And Government Relations Board Appointment To Support Strategic Initiatives
Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
DEEP SEA MINERALS CORP. FILES FINAL BASE SHELF PROSPECTUS AND RECEIVES FINAL RECEIPT
BIG BEAR GOLD CORP EXPANDS ITS WILL  PROJECT WITH THE ACQUISITION OF TWO STRATEGIC CLAIM BLOCKS
InflaRx to Report Second Quarter 2026 Results on  August 6, 2026
Gilat to Present at Upcoming Investor Conferences
Surge Copper Files NI 43-101 Technical Report for the Berg PFS
Fancamp and Goldera Complete Spin-Out Transaction and $5.5 Million Financing in Goldera; to Commence Trading August 5, 2026
HUTCHMED Reports 2026 Interim Results
SBCFX to Showcase Innovation and Global Growth Strategy at Forex Expo Dubai 2026
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors
Agios Reports Second Quarter 2026 Financial Results and Provides Business Update
Amneal Reports Second Quarter 2026 Financial Results
Quarterly Activities Report for Period Ended 30 June 2026
Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Dispatch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.